We recently published a paper called “GABAergic inhibition in dual-transmission cholinergic and GABAergic striatal interneurons is abolished in Parkinson disease“. Prof Tepper briefly commented it on Twitter. Here’s our answer: […]
A new study led by Prs. Yehezkel Ben-Ari & Constance Hammond (Neurochlore and B&A Therapeutics, Marseille, France) demonstrates that bumetanide, an antagonist of the NKCC1 chloride importer, normalizes the activity […]
Bumetanide for autism: more eye contact, less amygdala activation Nouchine Hadjikhani (Martinos Center for Biomedical Imaging, Harvard Medical School, Boston, Etats-Unis et Université de Gothenburg, Gothenburg, Suède), Eric Lemonnier (Centre […]
The birth process took millions of years to be developed. It must allow 4 major reactions: a passage from an immunologically protected environment to the external environment, the acquisition of […]
A large part of the therapeutic applications of biomedical research is generated in innovation incubators. More than 70% of new drugs come from discoveries made by small structures close to […]
This is a brain syndrome that has genetic and environmental links with Stockholm syndrome; the same acute manifestations of paranoia, headaches, the hibernation of the cortical structures involved in reasoning, […]
The case is emblematic of the protectionism of the US authorities. A German company discovers a product that would have a beneficial effect on female orgasm. After expensive but successful […]
